Non-symptomatic cases contribute to at least 50% of SARS-CoV-2 infection

NewsGuard 100/100 Score

A new study out of the University of Chicago has found that during the initial wave of the COVID-19 outbreak in New York City, only 1 in 5 to 1 in 7 cases of the virus was symptomatic. The research team found that non-symptomatic cases substantially contribute to community transmission, making up at least 50% of the driving force of SARS-CoV-2 infection. The results were published on Feb. 10 in the Proceedings of the National Academy of Sciences.

When the COVID-19 epidemic arrived in the U.S., the investigators noticed that it was very difficult to estimate what proportion of people infected with SARS-CoV-2 would go on to develop symptoms, partially due to the initial challenges with testing capacity.

Without testing capacity data, it's very difficult to estimate the difference between cases that were unreported due to a lack of testing and cases that were actually asymptomatic. We wanted to disentangle those two things, and since New York City was one of the first cities to report the daily number of tests completed, we were able to use those numbers to estimate how many COVID-19 cases were symptomatic."

Rahul Subramanian, Study First Author and PhD Student, Epidemiology, UChicago

While there are a number of existing models that use epidemiological data to estimate undetected case numbers and transmission rates, this is the first peer-reviewed model to incorporate data about daily testing capacity and changes in testing rates over time to provide a more accurate picture of what proportion of SARS-CoV-2 infections are symptomatic in a large U.S. city.

"Incorporating these data into the model showed that the proportion of individuals who are symptomatic for COVID-19 is somewhere between 13% and 18%," said senior author Mercedes Pascual, PhD, the Louis Block Professor of Ecology and Evolution at UChicago. "And regardless of uncertainty in all other parameters, we can tell that more that 50% of the transmission happening in the community is from people without symptoms ¬-- those who are asymptomatic and pre-symptomatic."

While this data analysis does not indicate how infectious asymptomatic individuals are, nor account for the new variants of the virus currently spreading in the U.S., the model provides additional support for the importance of following public health guidelines to reduce community transmission of the virus, whether individuals show symptoms.

"Even if asymptomatic people aren't transmitting the virus at high rates, they constitute something like 80% of all infections," said co-author Qixin He, now an assistant professor at Perdue University. "This proportion is quite surprising. It's crucial that everyone -- including individuals who don't show symptoms -- adhere to public health guidelines, such as mask wearing and social distancing, and that mass testing is made easily accessible to all."

The investigators say that these results also demonstrate that public health agencies need to make their testing protocols and numbers publicly available to allow these data to be incorporated into existing transmission models.

"Making this information available is as important as reporting the number of cases," said Pascual. "Otherwise, we have a discrepancy between the number and type of cases that are reported over time and the underlying transmission dynamics. These data are critical for epidemiological modeling."

Source:
Journal reference:

Subramanian, R., et al. (2021) Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity. Proceedings of the National Academy of Sciences. doi.org/10.1073/pnas.2019716118.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis